Doctor profile · Federal record

Dr. Jamal Misleh, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Newark, DE

  • NPI 1174665822
  • Accepts Medicare
  • MIPS 77.7 / 100 · 2023
  • 23 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
4701 Ogletown Stanton RD, Suite 3400
Newark, DE 197132055
(302) 366-1200
fax (302) 366-1700

Credentials & registration

NPPES · NUCC
NPI registered
February 2007 — 19 yrs on file
Profile last updated
June 15, 2009
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Delaware #C1-0008987

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1174665822. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
379,759
Distinct HCPCS
10
Medicare allowed
$8,591,819
HCPCS Description Services Patients Avg allowed
J9025 Injection, azacitidine, 1 mg 91,365 13 $0
J9271 Injection, pembrolizumab, 1 mg 66,000 56 $54
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 41,540 24 $3
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj 34,380 22 $48
J9263 Injection, oxaliplatin, 0.5 mg 31,940 23 $0
J0897 Injection, denosumab, 1 mg 16,140 57 $23
J9299 Injection, nivolumab, 1 mg 14,300 11 $30
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg 11,980 33 $40
J1100 Injection, dexamethasone sodium phosphate, 1 mg 8,312 157 $0
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 7,140 11 $1

In context: peer comparison

Among 10 peers in this city , average services per provider: 2,665. This provider delivers 142× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$249
Transactions
8
Manufacturers
7
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 1 $91.89
Novartis Pharmaceuticals Corporation 2 $53.63
ABBVIE INC. 1 $26.04
Kite Pharma, Inc. 1 $25.75
PFIZER INC. 1 $18.14
Celgene Corporation 1 $17.37
Karyopharm Therapeutics Inc. 1 $15.98

By nature of payment

Food and Beverage
$249

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,677
Patients
474
Total drug cost
$4,763,580
Drug Type Claims Patients Total cost
Acyclovir Generic 362 71 $6,659
Prednisone Generic 175 47 $1,450
Lenalidomide Generic 138 19 $2,158,928
Gabapentin Generic 120 35 $2,095
Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) Brand 113 41 $488
Eliquis (Apixaban) Brand 100 22 $91,138
Xarelto (Rivaroxaban) Brand 95 19 $65,682
Anastrozole Generic 88 26 $2,699
Prochlorperazine Maleate Generic 88 59 $1,181
Revlimid (Lenalidomide) Brand 78 19 $1,404,128

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Jamal Misleh's medical specialty?
Dr. Jamal Misleh practices Hematology & Oncology Physician in Newark, DE.
Where does Dr. Jamal Misleh practice?
Dr. Jamal Misleh practices at 4701 Ogletown Stanton RD, Newark, DE 197132055. Office phone: 3023661200.
What is Dr. Jamal Misleh's NPI?
Dr. Jamal Misleh's National Provider Identifier (NPI) is 1174665822, issued by NPPES.
Does Dr. Jamal Misleh accept Medicare assignment?
Yes. Dr. Jamal Misleh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jamal Misleh commonly perform?
Top Medicare-reported procedures in 2023: Injection, azacitidine, 1 mg (HCPCS J9025); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881). Source: CMS Medicare Physician & Other Practitioners file.